NOWDiagnostics, Inc.

NOWDiagnostics, Inc. (NOWDx) is a leader in developing over-the-counter (OTC) and point-of-care (POC) diagnostic tests. The company is headquartered in Springdale, Arkansas and specializes in rapid, in-home diagnostic tests that deliver results in minutes. NOWDx's product portfolio includes the First To Know® Syphilis Test, the first and only FDA-authorized over-the-counter home test for syphilis, and the ADEXUSDx® hCG Test. The First To Know® Syphilis Test is available nationwide through major retailers, pharmacies, drugstore locations, and online platforms including Amazon, as well as through public health initiatives. The company's focus is on advancing consumer healthcare through accessible, rapid diagnostic testing without requiring laboratory infrastructure or healthcare provider visits. NOWDx serves both direct-to-consumer markets and public health agencies, positioning its products for individuals seeking convenient, confidential testing solutions. The company maintains FDA authorization for its diagnostic products and actively participates in industry forums such as the J.P. Morgan Healthcare Conference, demonstrating commitment to advancing the OTC and POC diagnostic space.